Tempol prevents genotoxicity induced by vorinostat: role of oxidative DNA damage

Long-term effects of systemic cancer treatment on DNA oxidative damage: The potential for targeted therapies

(2012) Laura Vera-Ramirez et al.   CANCER LETTERS

The Antioxidant Tempol Reduces Carcinogenesis and Enhances Survival in Mice When Administered after Nonlethal Total Body Radiation

(2012) J. B. Mitchell et al.   CANCER RESEARCH

Prevention of γ-radiation induced cellular genotoxicity by tempol: Protection of hematopoietic system

(2012) Lakshmy Ramachandran et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Role of Nitrative and Oxidative DNA Damage in Inflammation-Related Carcinogenesis

(2012) Mariko Murata et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Evaluation of vitamin B12 effects on DNA damage induced by pioglitazone

(2012) Karem Alzoubi et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Genotoxicity assessment in patients with thalassemia minor

(2012) Suleimman A. Al-Sweedan et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Genotoxicity assessment in iron deficiency anemia patients using sister chromatid exchanges and chromosomal aberrations assays

(2012) Omar F. Khabour et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor

(2012) Sachiko Ezoe   International Journal of Environmental Research and Public Health

Superoxide-lowering therapy with TEMPOL reverses arterial dysfunction with aging in mice

(2011) Bradley S. Fleenor et al.   AGING CELL

Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells

(2011) Luca A. Petruccelli et al.   PLoS One

Pretreatment with anti-oxidants sensitizes oxidatively stressed human cancer cells to growth inhibitory effect of suberoylanilide hydroxamic acid (SAHA)

(2010) Hirak S. Basu et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Assessment of genotoxicity of waterpipe and cigarette smoking in lymphocytes using the sister-chromatid exchange assay: A comparative study

(2010) Omar F. Khabour et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS

Vorinostat in acute myeloid leukemia and myelodysplastic syndromes

(2010) Thomas Prebet et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Effects of tempol and redox-cycling nitroxides in models of oxidative stress

(2010) Christopher S. Wilcox   PHARMACOLOGY & THERAPEUTICS

Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents

(2010) M. Namdar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair

(2010) J.- H. Lee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting histone deacetylases: development of vorinostat for the treatment of cancer

(2010) Victoria M Richon   Epigenomics

Vorinostat in solid and hematologic malignancies

(2009) David Siegel et al.   Journal of Hematology & Oncology

Effect of Every-Other-Day Fasting on Spontaneous Chromosomal Damage in Rat's Bone-Marrow Cells

(2009) Mohammed Azab et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES

The nitroxide antioxidant Tempol affects metal-induced cyto- and genotoxicity in human lymphocytes in vitro

(2007) Anna Lewinska et al.   MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS